{"database": "lobbying", "table": "lobbying_activities", "rows": [[1591163, "31b93c9d-1693-4865-b9fc-0d8d63d911f0", "Q3", "G2G CONSULTING", 323136, "COMPASS BIOMED (FORMERLY KNOWN AS ARTERIOCYTE)", 2014, "third_quarter", "MED", "National Defense Authorization Act (HR 4435) to provide sufficient medical R&D funding to support the warfighter", "Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2014-10-17T09:07:21.047000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1591163"], "units": {}, "query_ms": 69.17861802503467, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}